Package Leaflet: Information for the User
Viaflo Glucose 10%Solution for Infusion
Active Substance: Glucose
Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.
This medicine is called “Viaflo Glucose 10% Solution for Infusion”, but will be referred to as “Viaflo Glucose 10%” throughout this leaflet.
Contents of the pack:
Viaflo Glucose 10% is a solution of sugar (glucose) in water. Glucose is one of the main sources of energy for the body. This solution for infusion provides 400 kilocalories per liter.
Viaflo Glucose 10% is used to:
dilute with water other medicines that are to be given by intravenous injection.
You will not be given Viaflo Glucose 10% if you have any of the following conditions:
If another medicine is added to your infusion solution, read its package leaflet. This will ensure that you can take that medicine.
Warnings and precautions
Viaflo Glucose 10% is a hypertonic (concentrated) solution. Your doctor will take this into account when calculating the amount of solution to be given.
If you develop or have developed any of the following conditions, inform your doctor.
This can increase the risk of low sodium levels in the blood and can cause headache, nausea, seizures, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
When you receive this infusion, your doctor will monitor:
Your doctor will adjust the amount of infusion solution to be given according to the results of the tests. These tests will indicate to your doctor if you need additional potassium, a blood chemical. If necessary, it can be given intravenously.
As Viaflo Glucose 10% contains sugar (glucose), it can cause high blood sugar levels (hyperglycemia). If this occurs, your doctor may:
This is very important:
This solution will not be given using the same needle as a blood transfusion, as it could damage the red blood cells or cause them to clump together.
Children
Viaflo Glucose 10% should be given to children with special care.
Children should receive Viaflo Glucose 10% from a doctor or nurse. The amount given will be determined by a doctor specializing in pediatric treatment and will depend on the child's age, weight, and condition. If it is used to administer or dilute another medicine, or if other medicines are given at the same time, the dose may also be affected.
When the infusion is given to children, your doctor will take blood and urine samples to monitor the amount of electrolytes such as potassium in the blood (plasma electrolytes).
Newborns - especially premature and low-birth-weight babies - are at higher risk of developing low or high blood sugar levels (hypo- or hyperglycemia). Therefore, they need close monitoring during treatment with intravenous glucose solutions to ensure adequate control of blood sugar levels and prevent possible long-term adverse effects. Low blood sugar levels in newborns can cause prolonged seizures, coma, and brain damage. High blood sugar levels can cause brain hemorrhages, bacterial or fungal infections, eye damage (retinopathy of prematurity), intestinal infections (necrotizing enterocolitis), lung problems (bronchopulmonary dysplasia), prolonged hospital stay, and death.
When given to a newborn, the solution bag may be connected to an infusion pump device, which allows for the exact administration of the required amount over a defined time interval. Your doctor or nurse will be monitoring the device to ensure safe administration.
Children (including neonates and older children) who are given Viaflo Glucose 10% are at higher risk of having low sodium levels in the blood (hyponatremia) and a brain disorder due to low sodium levels (hyponatremic encephalopathy).
Other medicines and Viaflo Glucose 10%
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Viaflo Glucose 10% and any other medicine taken at the same time may affect each other.
Do not use Viaflo Glucose 10% with certain hormones (catecholamines) including adrenaline or steroids as they increase blood sugar levels.
Some medicines affect the vasopressin hormone. These may include:
Using Viaflo Glucose 10% with food and drinks
You should ask your doctor what you can eat or drink.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Pregnancy
Viaflo glucose 10% can be used during pregnancy. However, caution should be exercised when using a glucose solution during labor.
Fertility
There is not enough data on the effect of glucose on fertility, although no effect is expected.
Breastfeeding
There is not enough data on the use of a glucose solution during breastfeeding, although no effect is expected. Viaflo glucose 10% can be used during breastfeeding.
However, if another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Ask your doctor or nurse for advice before driving or using machines.
Viaflo Glucose 10% will be given to you by a doctor or nurse. Your doctor will decide how much you need and when it should be given. This will depend on your age, weight, physical condition, and the reason for treatment. The amount you receive may also be affected by other treatments you are receiving.
You should not receive Viaflo Glucose 10% if there are particles floating in the solution or if the container is damaged in any way.
Generally, Viaflo Glucose 10% will be given to you through a plastic tube attached to a needle inserted into a vein. A vein in the arm is usually used to give the infusion. However, your doctor may give you the medicine in another way.
Before and during the infusion, your doctor will monitor:
Any unused solution should be discarded. You should not receive Viaflo Glucose 10% from a started bag.
If you receive more Viaflo Glucose 10% than you should
If you receive too much Viaflo Glucose 10% (overdose) or if it is given too quickly or too frequently, the following symptoms may occur:
!
If you develop any of these symptoms, tell your doctor immediately. Your infusion will be stopped or the infusion rate will be reduced. You will be given insulin and will receive treatment according to the symptoms.
If another medicine was added to Viaflo Glucose 10% before the overdose, that medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
In case of overdose or accidental ingestion, contact the Toxicology Information Service. Phone 915.620.420
If you stop the infusion with Viaflo Glucose 10%
Your doctor will decide when you should stop this infusion.
If you have any further questions about the use of this product, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects may include:
If another medicine has been added to the infusion solution, it may also cause side effects. These side effects will depend on the added medicine. You should read the list of possible symptoms in the package leaflet of the added medicine.
If you experience any side effects, the infusion should be stopped.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Viaflo Glucose 10% should not be administered after the expiry date stated on the bag and carton after EXP. The expiry date is the last day of the month shown.
Viaflo Glucose 10% should not be administered if there are particles floating in the solution or if the unit is damaged in any way.
Composition ofViaflo Glucose 10%
The active ingredient is glucose (as monohydrate): 100 g per liter.
The only other component is water for injectable preparations.
Formula per 250 ml
Glucose (as monohydrate): 25 g
Formula per 500 ml
Glucose (as monohydrate): 50 g
Formula per 1000 ml
Glucose (as monohydrate): 100 g
Appearance of Viaflo Glucose 10% and Container Contents
Viaflo Glucose 10% is a clear solution, without visible particles. It is supplied in polyolefin/polyamide plastic bags (Viaflo). Each bag is wrapped with a sealed protective overbag.
The bag sizes are:
Contents of the outer carton:
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturers
Marketing Authorization Holder:
Baxter, S.L.
Pouet de Camilo 2, 46394 Ribarroja del Turia (Valencia)
Spain
Manufacturer:
Bieffe Medital S.A.
Ctra de Biescas, Senegüé
22666 Sabiñánigo (Huesca)
Spain
Date of Last Revision of this Leaflet:April 2018
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
This information is intended only for healthcare professionals:
Handling and Preparation
The solution for infusion should be visually inspected before use.
Parenteral solutions should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Use the bag only if the solution is clear, does not contain visible particles, and the container is not damaged. It should be administered immediately after insertion of the infusion equipment.
Do not remove the bag from its overbag until ready for use.
The inner bag maintains the sterility of the product.
Do not connect plastic containers in series. This type of use can produce gas embolisms due to residual air dragged from the primary container before the administration of the liquid contained in the secondary container is completed.
The pressurization of intravenous solutions in flexible plastic containers to increase flow rates can result in a gas embolism if the residual air in the container is not fully evacuated before administration. The use of an intravenous administration set with a ventilation filter in the open position could cause a gas embolism. This type of intravenous administration set with the ventilation filter in the open position should not be used with flexible plastic containers.
The solution should be administered with sterile equipment using an aseptic technique. The equipment should be primed with the solution to prevent air from entering the system.
The addition of electrolytes may be indicated based on the patient's clinical needs.
Medicines can be added before infusion or during it through the resalable medication addition port. When used, the final osmolarity should be checked before parenteral administration. The mixture should be aseptic and performed carefully and meticulously. Solutions containing added medicines should not be stored and should be used immediately.
In order to avoid a potentially fatal overdose during the infusion of intravenous solutions in newborns, special attention should be paid to the method of administration. When using a syringe pump to administer fluids or medications intravenously to newborns, a liquid bag should not be left connected to the syringe.
When using an infusion pump, all clamps on the intravenous administration equipment should be closed before removing the administration set from the pump, or changing it. This is required regardless of whether the administration equipment has an anti-free flow device.
The complete device equipment and its administration through intravenous infusion should be frequently monitored.
Discard after single use.
Discard unused remnants.
Do not reconnect partially used bags.
Do not store solutions containing other medications.
An aseptic technique should be used when adding medications to Viaflo Glucose 10%.
Mix the solution well when adding medications.
Use sterile material for preparation and administration.
Warning: Added medications may be incompatible.
To add medication before administration
To add medication during administration
The chemical and physical stability of the added medications in the pH of Viaflo Glucose 10% in the Viaflo container should be determined before use.
From a microbiological point of view, the diluted product should be used immediately unless the reconstitution has been carried out under aseptic, controlled, and validated conditions. If not used immediately, the storage conditions and times are the responsibility of the user.
The glucose solution should not be administered simultaneously with, before, or after a blood transfusion through the same infusion equipment, as it may cause hemolysis and clot formation.
The incompatibility of the medications to be added with Viaflo Glucose 10% should be evaluated before adding them.
In the absence of incompatibility studies, this product should not be mixed with others.
The summary of product characteristics of the medication to be added should be consulted.
Before adding a medication, verify that it is soluble and stable in water within the pH range of Viaflo Glucose 10% (pH 3.5 to 6.5).
When compatible medication is added to Viaflo Glucose 10%, the solution should be administered immediately.
Incompatible added medications should not be used.